| Title |
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
|
|---|---|
| Published in |
Psychopharmacology, March 2006
|
| DOI | 10.1007/s00213-006-0358-7 |
| Pubmed ID | |
| Authors |
Jordi Riba, Sergio Romero, Eva Grasa, Esther Mena, Ignasi Carrió, Manel J. Barbanoj |
| Abstract |
Ayahuasca is a South American psychoactive plant tea which contains the serotonergic psychedelic N,N-dimethyltryptamine (DMT) and monoamine-oxidase inhibitors that render DMT orally active. Previous investigations with ayahuasca have highlighted a psychotropic effect profile characterized by enhanced introspective attention, with individuals reporting altered somatic perceptions and intense emotional modifications, frequently accompanied by visual imagery. Despite recent advances in the study of ayahuasca pharmacology, the neural correlates of acute ayahuasca intoxication remain largely unknown. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 60% |
| Unknown | 2 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 80% |
| Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 323 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 1% |
| Brazil | 4 | 1% |
| Switzerland | 1 | <1% |
| Netherlands | 1 | <1% |
| Spain | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 311 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 64 | 20% |
| Student > Master | 54 | 17% |
| Researcher | 41 | 13% |
| Student > Ph. D. Student | 29 | 9% |
| Other | 23 | 7% |
| Other | 41 | 13% |
| Unknown | 71 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 59 | 18% |
| Medicine and Dentistry | 41 | 13% |
| Neuroscience | 39 | 12% |
| Agricultural and Biological Sciences | 34 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 5% |
| Other | 53 | 16% |
| Unknown | 82 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 October 2023.
All research outputs
#1,792,468
of 24,244,537 outputs
Outputs from Psychopharmacology
#431
of 5,516 outputs
Outputs of similar age
#3,088
of 68,744 outputs
Outputs of similar age from Psychopharmacology
#3
of 42 outputs
Altmetric has tracked 24,244,537 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,516 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 68,744 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.